Clarifying the causal contrast: An empirical example applying the prevalent new user study design.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jessica C,Young

第一单位： Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Real World Evidence & Patient Outcomes, CERobs Consulting, LLC, Wrightsville Beach, North Carolina, USA.;Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

作者： Jessica C,Young ^[1] ; Michael,Webster-Clark ^[2] ; Shahar,Shmuel ^[3] ; Elizabeth M,Garry ^[4] ; Panagiotis,Mavros ^[5] ; Til,Stürmer ^[6] ; Cynthia J,Girman ^[3]

作者单位： Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Real World Evidence & Patient Outcomes, CERobs Consulting, LLC, Wrightsville Beach, North Carolina, USA.;Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. ^[1] Real World Evidence & Patient Outcomes, CERobs Consulting, LLC, Wrightsville Beach, North Carolina, USA.;Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;McGill University Department of Biostatistics, Epidemiology, and Occupational Health, Quebec, Canada. ^[2] Real World Evidence & Patient Outcomes, CERobs Consulting, LLC, Wrightsville Beach, North Carolina, USA.;Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. ^[3] Scientific Research, Aetion, Inc., New York, New York, USA. ^[4] KREDHERA, LLC, Hampton, New Jersey, USA.;Janssen Scientific Affairs, Janssen Pharmaceutical Companies of J&J, Titusville, New Jersey, USA. ^[5] Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. ^[6]

关键词 GLP‐1 RA prevalent new user design sulfonylurea

主题词人类(Humans);糖尿病, 2型(Diabetes Mellitus, Type 2);磺酰脲化合物(Sulfonylurea Compounds);危险因素(Risk Factors);心力衰竭(Heart Failure);胰高血糖素样肽1(Glucagon-Like Peptide 1);降血糖药(Hypoglycemic Agents)

DOI 10.1002/pds.5790

PMID 38575389

发布时间 2024-11-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交